ID   BERB
AC   CVCL_LJ68
DR   Wikidata; Q54796065
RX   Patent=US5443954;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10635.
CC   Characteristics: Weakly tumorigenic derivative of BEAS-2B.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3430; ERBB2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0168 ! BEAS-2B
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 13
CH   CVCL_LJ69 ! BERB subclone 2
//
RX   Patent=US5443954;
RA   Reddel, Roger Robert
RA   Yang, Ke
RA   Rhim, Johng Sik
RA   Brash, Douglas E.
RA   Su, Robert T.
RA   Lechner, John F.
RA   Gerwin, Brenda Isen
RA   Harris, Curtis Craig
RA   Amstad, Paul A.
RT   "Immortalized non-tumorigenic human bronchial epithelial cell lines.";
RL   Patent number US5443954, 22-Aug-1995.
//